Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
jueves, 7 de mayo de 2026
People judge GLP-1 users more harshly than dieters
https://www.news-medical.net/news/20260507/People-judge-GLP-1-users-more-harshly-than-dieters.aspx
Even as GLP-1 medications transform obesity treatment, new research reveals a surprising reality: people may face stigma whether they lose weight, regain it, or never lose it at all.
In a recent study published in the International Journal of Obesity, a group of researchers examined whether people experience stigma after losing or regaining weight following the use and discontinuation of glucagon-like peptide-1 receptor agonist (GLP-1RAs) medications.
No hay comentarios:
Publicar un comentario